Severe hypercortisolism: A medical emergency requiring urgent intervention

Critical Care Medicine

Volumn 38, Issue 7, 2010, Pages 1598-1601

  Lutgers, Helen L ^a   Vergragt, Joris ^b   Dong, Phi Vu ^a   De Vries, Jakob ^a   Dullaart, Robin P F ^a   Van Den Berg, Gerrit ^a   Ligtenberg, Jack J M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Refaja Ziekenhuis Stadskanaal   (Netherlands)

Author keywords

adrenalectomy; cortisol; Cushing's syndrome

Indexed keywords

CORTICOTROPIN; ETOMIDATE; HYDROCORTISONE;

ADRENAL HYPERPLASIA; ADRENALECTOMY; ADULT; ARTICLE; CASE REPORT; CONTINUOUS INFUSION; CORTICOTROPIN BLOOD LEVEL; CUSHING DISEASE; DISEASE SEVERITY; EMERGENCY CARE; FEMALE; HISTOPATHOLOGY; HORMONE RELEASE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERCORTISOLISM; INTENSIVE CARE UNIT; PHEOCHROMOCYTOMA; PRIORITY JOURNAL;

EID: 77954083669     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181e47b7a     Document Type: Article

References (22)

1. Lindholm J, Juul S, Jorgensen JO, et al: Incidence and late prognosis of Cushing's syndrome: A population-based study. J Clin En-docrinol Metab 2001; 86:117-123
2. Mancini T, Kola B, Mantero F, et al: High cardiovascular risk in patients with Cush-ing's syndrome according to 1999 WHO/ISH guidelines. Clin Endocrinol (Oxf) 2004; 61: 768-777
3. Arnaldi G, Angeli A, Atkinson AB, et al: Diagnosis and complications of Cushing's syndrome: A consensus statement. J Clin Endo-crinol Metab 2003; 88:5593-5602
4. Newell-Price J, Bertagna X, Grossman AB, et al: Cushing's syndrome. Lancet 2006; 367: 1605-1617
5. Torpy DJ, Mullen N, Ilias I, et al: Association of hypertension and hypokalemia with Cush-ing's syndrome caused by ectopic ACTH secretion: A series of 58 cases. Ann N Y Acad Sci 2002; 970:134-144
6. Greening JE, Brain CE, Perry LA, et al: Efficient short-term control of hypercortisolae-mia by low-dose etomidate in severe paedi-atric Cushing's disease. Horm Res 2005; 64: 140-143
7. Mettauer N, Brierley J: A novel use of etomidate for intentional adrenal suppression to control severe hypercortisolemia in childhood. Pediatr Crit Care Med 2009; 10:e37-e40
8. Oosterhuis JK, van den Berg G, Monteban-Kooistra WE, et al: Life-threatening Pneu-mocystis jiroveci pneumonia following treatment of severe Cushing's syndrome. Neth J Med 2007; 65:215-217
9. Ligtenberg JJ, Girbes AR, Beentjes JA: Hormones in the critically ill patient: To intervene or not to intervene. Int Care Med 2001; 27:1567-1577
10. Ilias I, Torpy DJ, Pacak K, et al: Cushing's Syndrome due to ectopic corticotropin secretion: Twenty years' experience at the National Institutes of Health. J Clin Endocrinol Metab 2005; 90:4955-4962
11. Isidori AM, Kaltsas GA, Pozza C, et al: The ectopic adrenocorticotropin syndrome: Clinical features, diagnosis, management, and long-term follow-up. J Clin Endocrinol Metab 2006; 91:371-377
12. Auphan N, DiDonato JA, Rosette C, et al: Immunosuppression by glucocorticoids: Inhibition of NF-kappa B activation through induction of I kappa B synthesis. Science 1995; 270:286-290
13. Graham BS, Tucker WS Jr: Opportunistic infections in endogenous Cushing's syndrome. Ann Intern Med. 1984; 101:334-338
14. Sarlis NJ, Chanock SJ, Nieman LK: Corti-solemic indices predict severe infections in Cushing's syndrome due to ectopic production of adrenocorticotropin. J Clin Endocri-nol Metab 2000; 85:42-47
15. Rufini V, Calcagni ML, Baum RP: Imaging of neuroendocrine tumors. Semin Nuclear Med 2006; 36:228-247
16. Fiebrich HB, Brouwers AH, van Bergeijk L, et al: Image in endocrinology: Localization of an adrenocorticotropin-producing pheochro-mocytoma using 18F-dihydroxyphenylala-nine positron emission tomography. J Clin Endocrinol Metab 2009; 94:748-749
17. Biller BM, Grossman AB, Stewart PM, et al: Treatment of adrenocorticotropin-dependent Cushing's syndrome: A consensus statement. J Clin Endocrinol Metab 2008; 93:2454-2462
18. Schulte HM, Benker G, Reinwein D, et al: Infusion of low dose etomidate: Correction of hypercortisolemia in patients with Cushing's syndrome and dose-response relationship in normal subjects. J Clin Endocrinol Metab 1990; 70:1426-1430
19. Drake WM, Perry LA, Hinds CJ, et al: Emergency and prolonged use of intravenous eto-midate to control hypercortisoleamia in a patient with Cushing's syndrome and peritonitis. J Clin Endocrinol Metab 1998; 83: 3542-3544
20. Chow JT, Thompson GB, Grant CS, et al: Bilateral laparoscopic adrenalectomy for cor-ticotrophin-dependent Cushing's syndrome: a review of the Mayo Clinic experience. Clin Endocrinol (Oxf) 2008; 68:513-519
21. Yip L, Lee JE, Shapiro SE, et al: Surgical management of heredetary pheochromocy-toma, J Am Coll Surg 2004; 198:525-534
22. de Graaf JS, Dullaart RP, Zwierstra RP: Complications after bilateral adrenalectomy for pheochromocytoma in multiple endocrine neoplasia type 2-a plea to conserve adrenal function. Eur J Surg 1999; 165:843-846